Nivolumab and immune-mediated colitis.

Walker, Heather; Brennan, Paul; Groome, Maximillian; Walsh, Shaun; Carey, Frank

Walker, Heather; Brennan, Paul; Groome, Maximillian; Walsh, Shaun; Carey, Frank.

Afiliação

Walker H; Ninewells Hospital and Medical School, University of Dundee and NHS Tayside Dundee UK.
Brennan P; Ninewells Hospital and Medical School, University of Dundee and NHS Tayside Dundee UK.
Groome M; Department of Gastroenterology Ninewells Hospital and Medical School Dundee UK.
Walsh S; Department of Gastroenterology Ninewells Hospital and Medical School Dundee UK.
Carey F; Department of Pathology Ninewells Hospital and Medical School Dundee UK.

Clin Case Rep ; 7(4): 644-647, 2019 Apr.

Article em En | MEDLINE | ID: mdl-30997054

Palavras-chave

Nivolumab; PD1 receptor; immunemediated colitis; immuneregulated adverse events

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Clin Case Rep Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google